Citigroup Inc. lifted its position in shares of The Beauty Health Company (NASDAQ:SKIN – Get Rating) by 26.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 205,664 shares of the company’s stock after buying an additional 43,542 shares during the period. Citigroup Inc. owned about 0.16% of Beauty Health worth $1,872,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently modified their holdings of the company. UBS Group AG boosted its position in shares of Beauty Health by 272.8% during the fourth quarter. UBS Group AG now owns 20,413 shares of the company’s stock worth $186,000 after buying an additional 14,938 shares during the period. Swiss National Bank boosted its position in Beauty Health by 2.0% during the fourth quarter. Swiss National Bank now owns 218,600 shares of the company’s stock valued at $1,989,000 after purchasing an additional 4,300 shares during the last quarter. Arizona State Retirement System boosted its position in Beauty Health by 4.0% during the fourth quarter. Arizona State Retirement System now owns 25,544 shares of the company’s stock valued at $232,000 after purchasing an additional 984 shares during the last quarter. State Board of Administration of Florida Retirement System boosted its position in Beauty Health by 19.7% during the fourth quarter. State Board of Administration of Florida Retirement System now owns 12,990 shares of the company’s stock valued at $118,000 after purchasing an additional 2,140 shares during the last quarter. Finally, Handelsbanken Fonder AB acquired a new position in Beauty Health during the fourth quarter valued at approximately $96,000. 78.37% of the stock is owned by institutional investors and hedge funds.
Beauty Health Trading Up 1.3 %
Shares of NASDAQ SKIN opened at $9.67 on Friday. The company has a current ratio of 10.35, a quick ratio of 8.66 and a debt-to-equity ratio of 4.98. The Beauty Health Company has a 1-year low of $8.25 and a 1-year high of $16.02. The business’s 50 day moving average is $11.65 and its 200-day moving average is $11.10.
Beauty Health (NASDAQ:SKIN – Get Rating) last announced its earnings results on Tuesday, February 28th. The company reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.04. The company had revenue of $98.13 million for the quarter, compared to analyst estimates of $94.97 million. Beauty Health had a negative return on equity of 3.57% and a negative net margin of 2.77%. Analysts expect that The Beauty Health Company will post 0.02 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several research analysts recently commented on SKIN shares. Cowen reduced their price target on Beauty Health from $20.00 to $15.00 and set an “outperform” rating for the company in a research report on Thursday, February 16th. Benchmark restated a “buy” rating and issued a $23.00 price objective on shares of Beauty Health in a research note on Tuesday, March 14th. DA Davidson upped their price objective on Beauty Health from $32.00 to $35.00 and gave the company a “buy” rating in a research note on Wednesday, March 1st. BNP Paribas upgraded Beauty Health from an “underperform” rating to a “neutral” rating in a research note on Monday, March 20th. Finally, Canaccord Genuity Group restated a “buy” rating and issued a $18.00 price objective on shares of Beauty Health in a research note on Tuesday, March 28th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, Beauty Health presently has an average rating of “Moderate Buy” and a consensus price target of $19.50.
About Beauty Health
(Get Rating)
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company’s flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Beauty Health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Beauty Health wasn’t on the list.
While Beauty Health currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Source: marketbeat.com
Citigroup Inc. lifted its position in shares of The Beauty Health Company (NASDAQ:SKIN – Get Rating) by 26.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 205,664 shares of the company’s stock after buying an additional 43,542 shares during the period. Citigroup Inc. owned about 0.16% of Beauty Health worth $1,872,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently modified their holdings of the company. UBS Group AG boosted its position in shares of Beauty Health by 272.8% during the fourth quarter. UBS Group AG now owns 20,413 shares of the company’s stock worth $186,000 after buying an additional 14,938 shares during the period. Swiss National Bank boosted its position in Beauty Health by 2.0% during the fourth quarter. Swiss National Bank now owns 218,600 shares of the company’s stock valued at $1,989,000 after purchasing an additional 4,300 shares during the last quarter. Arizona State Retirement System boosted its position in Beauty Health by 4.0% during the fourth quarter. Arizona State Retirement System now owns 25,544 shares of the company’s stock valued at $232,000 after purchasing an additional 984 shares during the last quarter. State Board of Administration of Florida Retirement System boosted its position in Beauty Health by 19.7% during the fourth quarter. State Board of Administration of Florida Retirement System now owns 12,990 shares of the company’s stock valued at $118,000 after purchasing an additional 2,140 shares during the last quarter. Finally, Handelsbanken Fonder AB acquired a new position in Beauty Health during the fourth quarter valued at approximately $96,000. 78.37% of the stock is owned by institutional investors and hedge funds.
Beauty Health Trading Up 1.3 %
Shares of NASDAQ SKIN opened at $9.67 on Friday. The company has a current ratio of 10.35, a quick ratio of 8.66 and a debt-to-equity ratio of 4.98. The Beauty Health Company has a 1-year low of $8.25 and a 1-year high of $16.02. The business’s 50 day moving average is $11.65 and its 200-day moving average is $11.10.
Beauty Health (NASDAQ:SKIN – Get Rating) last announced its earnings results on Tuesday, February 28th. The company reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.04. The company had revenue of $98.13 million for the quarter, compared to analyst estimates of $94.97 million. Beauty Health had a negative return on equity of 3.57% and a negative net margin of 2.77%. Analysts expect that The Beauty Health Company will post 0.02 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several research analysts recently commented on SKIN shares. Cowen reduced their price target on Beauty Health from $20.00 to $15.00 and set an “outperform” rating for the company in a research report on Thursday, February 16th. Benchmark restated a “buy” rating and issued a $23.00 price objective on shares of Beauty Health in a research note on Tuesday, March 14th. DA Davidson upped their price objective on Beauty Health from $32.00 to $35.00 and gave the company a “buy” rating in a research note on Wednesday, March 1st. BNP Paribas upgraded Beauty Health from an “underperform” rating to a “neutral” rating in a research note on Monday, March 20th. Finally, Canaccord Genuity Group restated a “buy” rating and issued a $18.00 price objective on shares of Beauty Health in a research note on Tuesday, March 28th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, Beauty Health presently has an average rating of “Moderate Buy” and a consensus price target of $19.50.
About Beauty Health
(Get Rating)
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company’s flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Beauty Health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Beauty Health wasn’t on the list.
While Beauty Health currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Source: marketbeat.com
